BRIEF-Valeant Pharma ups offering to $900 mln from $850 mln principal amount of notes

Mon Nov 18, 2013 6:43am EST

Nov 18 (Reuters) - Valeant Pharmaceuticals International Inc : * Says has priced its offering of 5.625% senior unsecured notes due 2021-SEC

filing * Valeant pharmaceuticals international inc -co increased the offering to $900

million from $850 million aggregate principal amount of notes * Source text () * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.